[thechat] pure evil: Tobacco giant buys rights to lung cancer drugs
Luther, Ron
Ron.Luther at compaq.com
Mon Dec 3 15:36:20 CST 2001
Hi Joe,
A very interesting issue! Lots of interesting economics and dynamics in
there ... and interesting stories too! (Even some good ones like Gerber
continuing to make their 'meat substitute' babyfood - even at a loss -
because it helps some kids with an unusual condition.)
* If your new cure is 'too' effective, you eliminate your market need
before you recoup your R&D expenses.
* If 'too few' people suffer from a malady, it isn't cost effective to
even research a cure.
RonL.
(Hey! Did I tell you about the time I tried to sell Marketing (at the
telco) on an ad campaign showing the benefits custom calling services
would have for organized crime?
Call Waiting:
"... yeah, I'll take 20 kilos" (BEEP) "... wait a minute, another call
coming in"
<click>
"Yeah?"
"Cheese it, Tony! The heat!"
:-)
)
-----Original Message-----
From: Joe Crawford [mailto:jcrawford at avencom.com]
Subject: Re: [thechat] pure evil: Tobacco giant buys rights to lung
cancer drugs
The natural tension is between two things -- the ability of people who
develop cures to reap a benefit from the work put in to developing those
cures (and hopefully grow enough to get more) -- and the ability of the
sick to get access to those cures.
There's a similar problem in the drug industry.
More information about the thechat
mailing list